Xlife Sciences AG Logo

Xlife Sciences AG

ISIN: CH0461929603 | Ticker: XLS | LEI: 984500AH590BE88BB517
Sector: Health CareSub-Industry: Pharmaceuticals
Country: Switzerland

About Xlife Sciences AG

Company Description

We bring selected projects in the four areas of technology platforms, biotechnologies/therapies, medical technology (health technology), and artificial intelligence in the life science sector and digital health to the next stage of development.We lead these projects from the very beginning after an invention has been made and typically commercialize them after two to three years by, e.g., a trade sale, by entering into a joint venture with an industrial partner or by outlicensing patents.

For the identification, selection and development of our projects, we benefit from our growing network with universities, clinical centers and research institutions.Typically, we incorporate a separate Portfolio company for each project. Currently, we have a portfolio of 22 Portfolio Companies, in which we hold at least a minority stake. More information about these Portfolio Companies can be found here.

Served area





Talacker 35, 8001 Zurich – Switzerland

Filings & Publications

Sign up and we will give you access!

Insider Trades

Date Trading entity / Person Association Trade type Volume
15.06.22 None Executive member Buy CHF 6,000.00
15.06.22 None Executive member Buy CHF 3,000.00
14.06.22 None Executive member Buy CHF 15,500.00
10.06.22 None Executive member Buy CHF 6,728.90
07.06.22 None Executive member Buy CHF 34,800.00
03.06.22 None Executive member Buy CHF 3,540.00
24.05.22 None Executive member Buy CHF 3,400.00
17.05.22 None Executive member Buy CHF 10,794.20
13.05.22 None Executive member Buy CHF 3,690.00
10.05.22 None Executive member Buy CHF 1,935.00

Capital markets information






Health Care

Industry Group

Pharmaceuticals, Biotechnology & Life Sciences





Listed Stock Exchange

SIX Swiss Exchange

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.